O75530 (EED_HUMAN) Homo sapiens (Human)
Polycomb protein EED UniProtKBInterProSTRINGInteractive Modelling
Available Structures
74 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| G4 RNA-mediated PRC2 dimer |
Heteromer A0A6I9KXB3; Q09028; Q15022; Q15910; Q6ZN18; | 100 | 14×ZN; | |||
| Human PRC2 - RvLEAM (short) (1:6 molar ratio), cross-linked 10 min |
Heteromer Q09028; Q15022; Q15910; Q6ZN18; Q92833; | 100 | 7×ZN; | |||
| Crystal structure of EED [G255D] in complex with EZH2 peptide and EED226 compound |
Heteromer Q15910; | 99.73 | 1×GOL; 1×73K; | |||
| EED in complex with an allosteric PRC2 inhibitor EED666 |
Heteromer Q15910; | 100 | 1×GOL; 1×LQB; | |||
| Crystal Structure of EED in complex with EB22 |
Heteromer | 100.0 | 16×UNX; | |||
| Structure of Human Polycomb Repressive Complex 2 (PRC2) with oncogenic histone H3K27M peptide |
Heteromer P68431; Q15022; Q15910; Q92833; | 100 | 8×ZN; 1×SAH; | |||
| Structure of human PRC2-EZH1 containing phosphorylated SUZ12 |
Heteromer P68431; Q15022; Q92800; | 100 | 8×ZN; 1×SAM; | |||
| Structure of Human Polycomb Repressive Complex 2 (PRC2) with inhibitor |
Heteromer Q15022; Q15910; Q92833; | 100 | 8×ZN; 1×74D; | |||
| PRC2:EZH1_A from a dimeric PRC2 bound to a nucleosome |
Heteromer Q09028; Q15022; Q92800; | 100 | 7×ZN; | |||
| PRC2:EZH1_B from a dimeric PRC2 bound to a nucleosome |
Heteromer Q09028; Q15022; Q92800; | 100 | 7×ZN; | |||
| Cryo-EM structure of PRC2:EZH1-AEBP2-JARID2 |
Heteromer Q09028; Q15022; Q6ZN18; Q92800; Q92833; | 100 | 8×ZN; | |||
| EED in complex with PRC2 allosteric inhibitor compound 7 |
Heteromer Q15910; | 100.0 | 2×CL; 1×EKF; | |||
| EED in complex with PRC2 allosteric inhibitor compound 6 |
Heteromer Q15910; | 100 | 2×CL; 1×EKR; | |||
| Crystal structure of EED in complex with EZH2 peptide and compound 11# |
Heteromer Q15910; | 100 | 1×EJU; | |||
| EED in complex with PRC2 allosteric inhibitor EED210 |
Heteromer Q15910; | 100.0 | 1×LQE; | |||
| EED in complex with PRC2 allosteric inhibitor compound 8 |
Heteromer Q15910; | 100 | 1×LQG; | |||
| EED in complex with PRC2 allosteric inhibitor compound 11 |
Heteromer Q15910; | 100 | 1×LQH; | |||
| Crystal Structure of an EZH2-EED Complex in an Oligomeric State |
Heteromer Q15910; | 100.0 | ||||
| EED in complex with PRC2 allosteric inhibitor compound 22 (MAK683) |
Heteromer Q15910; | 100.0 | 3×CL; 1×EJR; | |||
| EED in complex with PRC2 allosteric inhibitor EED162 |
Heteromer Q15910; | 100.0 | 1×LQF; | |||
| EED in complex with PRC2 allosteric inhibitor EED709 |
Heteromer Q15910; | 100.0 | 1×LQD; | |||
| EED in complex with an allosteric PRC2 inhibitor |
Heteromer Q15910; | 100.0 | 1×73K; | |||
| Crystal structure of EED in complex with H3K27Me3 peptide and 3-(benzo[d][1,3]dioxol-4-ylmethyl)pip… |
Heteromer Q15910; | 100.0 | 1×7W7; | |||
| Crystal structure of EED in complex with H3K27Me3 peptide and 6-(benzo[d][1,3]dioxol-4-ylmethyl)-5,… |
Heteromer Q15910; | 100.0 | 1×GOL; 2×YT3; 1×7WD; | |||
| Cryo-EM structure of PRC2 in complex with the long isoform of AEBP2 |
Heteromer Q09028; Q15022; Q15910; Q6ZN18; | 100 | ||||
| PRC2-AEBP2-JARID2 bound to H2AK119ub1 nucleosome |
Heteromer P02281; P06897; P0CG48; P62799; P84233; Q09028; Q15022; Q15910; Q6ZN18; Q92833; | 100 | 1×MG; 1×SAH; 1×ZN; | |||
| Automethylated PRC2 dimer bound to nucleosome |
Heteromer P02281; P06897; P62799; P84233; Q09028; Q15022; Q15910; Q6ZN18; | 100 | 2×SAH; | |||
| PRC2-J119-450 monomer bound to H1-nucleosome |
Heteromer P02281; P06897; P07305; P62799; P84233; Q09028; Q15022; Q15910; Q6ZN18; Q92833; | 100 | 1×SAH; | |||
| PRC2 monomer bound to nucleosome |
Heteromer P02281; P06897; P62799; P84233; Q09028; Q15022; Q15910; Q6ZN18; | 100 | 1×SAH; | |||
| Cryo-EM structure of PRC2 bound to cofactors AEBP2 and JARID2 in the Extended Active State |
Heteromer Q09028; Q15022; Q15910; Q6ZN18; Q92833; | 100 | ||||
| Cryo-EM structure of PRC2 bound to cofactors AEBP2 and JARID2 in the Compact Active State |
Heteromer Q09028; Q15022; Q15910; Q6ZN18; Q92833; | 100 | ||||
| Structure of Hs/AcPRC2 in complex with a pyridone inhibitor |
Heteromer G1KPH4; Q15022; Q15910; | 100.0 | 1×6BN; 7×ZN; | |||
| Human Polycomb Repressive Complex 2 in complex with GSK126 inhibitor |
Heteromer Q15022; Q15910; | 100.0 | 8×ZN; 1×A9G; | |||
| Crystal structure of EED in complex with PALI1-K1219me3 peptide |
Heteromer Q96JN0; | 100 | ||||
| Crystal structure of EED in complex with PALI1-K1241me3 peptide |
Heteromer Q96JN0; | 100.0 | ||||
| Structural basis of EZH2 recognition by EED |
Heteromer Q61188; Q921E6; | 100.0 | ||||
| EED: A Novel Histone Trimethyllysine Binder Within The EED-EZH2 Polycomb Complex |
Heteromer P62805; | 100 | ||||
| Crystal structure of Eed in complex with a trimethylated histone H4K20 peptide |
Heteromer P62805; | 99.72 | ||||
| Crystal structure of EED in complex with a trimethylated Jarid2 peptide |
Heteromer Q92833; | 100 | ||||
| Structure of Hs/AcPRC2 in complex with 5,8-dichloro-2-[(4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin… |
Heteromer G1KPH4; Q15022; | 100 | 7×ZN; 1×CJD; | |||
| Structure of the primary oncogenic mutant Y641N Hs/AcPRC2 in complex with a pyridone inhibitor |
Heteromer G1KPH4; Q15022; Q15910; | 100 | 1×6BN; 7×ZN; | |||
| Structure of Hs/AcPRC2 in complex with 5,8-dichloro-7-(3,5-dimethyl-1,2-oxazol-4-yl)-2-[(4,6-dimeth… |
Heteromer G1KPH4; Q15022; | 100 | 7×ZN; 1×CJG; | |||
| EED in complex with PRC2 allosteric inhibitor EED396 | monomer | 100.0 | 1×GOL; 1×PR; 1×LQA; | |||
| Crystal structure of human EED | monomer | 100 | 1×XB7; 27×UNX; | |||
| Crystal structure of Eed in complex with a trimethylated histone H1K26 peptide | monomer | 99.72 | ||||
| Crystal Structure of EED in Complex with UNC4859 | monomer | 100 | 1×SO4; 11×UNX; | |||
| Crystal structure of EED in complex with 6-(2-fluoro-5-methoxybenzyl)-1-isopropyl-5,6,7,8-tetrahydr… | monomer | 100.0 | 1×7VV; 1×GOL; | |||
| Crystal structure of EED in complex with 3-(3-methoxybenzyl)piperidine hydrochloride | monomer | 100.0 | 1×FMT; 1×7VY; | |||
| CRYSTAL STRUCTURE OF EED WITH MRTX-1919 | monomer | 100 | 2×NA; 1×9L0; 2×EDO; 13×FMT; | |||
| Crystal structure of Eed in complex with NDSB-195 | monomer | 99.72 | 1×NDS; | |||
| Complex structure of EED and trimethylated H3K4 | monomer | 100 | ||||
| Complex structure of EED and trimethylated H3K9 | monomer | 100 | ||||
| CRYSTAL STRUCTURE OF EED WITH MRTX-2219 | monomer | 100 | 1×9JL; 2×FMT; | |||
| Crystal structure of Eed in complex with a trimethylated histone H3K27 peptide | monomer | 100 | ||||
| Targeting the PRC2 complex through a novel protein-protein interaction inhibitor of EED | monomer | 100 | 1×6PU; | |||
| Structure of EED bound to inhibitor 1056 | monomer | 99.72 | 3×Q3A; 1×NA; 1×FMT; | |||
| Structure of EED bound to EEDi-4259 | monomer | 99.72 | 1×ZNG; | |||
| EED-H3K79me3 | monomer | 100 | ||||
| Structure of EED in complex with H3K27me3 | monomer | 100 | ||||
| Structure of EED bound to inhibitor 5285 | monomer | 99.72 | 2×Q3D; 1×GOL; | |||
| Structure of EED bound to EEDi-6068 | monomer | 99.72 | 1×ZMY; 1×FMT; | |||
| Crystal structure of Eed in complex with a trimethylated histone H3K9 peptide | monomer | 99.72 | ||||
| Polycomb protein EED in complex with inhibitor: (3R,4S)-1-[(2-methoxyphenyl)methyl]-N,N-dimethyl-4-… | monomer | 100 | 1×LQD; | |||
| Polycomb protein EED in complex with inhibitor: (3R,4S)-1-[(1S)-7-fluoro-2,3-dihydro-1H-inden-1-yl]… | monomer | 100 | 1×82G; | |||
| Polycomb protein EED in complex with inhibitor: (3R,4S)-1-[(2-bromo-6-fluorophenyl)methyl]-N,N-dime… | monomer | 100 | 1×82D; | |||
| EED in complex with a triazolopyrimidine | monomer | 100.0 | 1×L9W; | |||
| EED in complex with compound 4 | monomer | 100.0 | 1×L9W; | |||
| Polycomb protein EED in complex with inhibitor: 2-[4-(4-{(3S,4R)-4-(dimethylamino)-1-[(2-fluoro-6-m… | monomer | 100 | 1×7XG; | |||
| EED in complex with a triazolopyrimidine | monomer | 100.0 | 1×L9W; | |||
| EED in complex with compound 4 | monomer | 100.0 | 3×MG; 1×L9W; | |||
| EED in complex with a methyl-thiazole | monomer | 100.0 | 2×CA; 1×L9W; | |||
| EED in complex with a cyano-benzofuran | monomer | 100.0 | 1×CA; 1×L9W; | |||
| EED in complex with compound 4 | monomer | 100.0 | 1×L9W; | |||
| Structure of EED in apo form | monomer | 100 | ||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8fyh.1.H | monomer | 0.82 | 100.00 | |||
| 5obm.152.A | monomer | 0.54 | 14.43 | |||
5 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 8fyh.1.H | monomer | 0.75 | 100.00 | |||
| Isoform 2 | 8hao.1.D | monomer | 0.51 | 14.74 | |||
| Isoform 3 | 8fyh.1.H | monomer | 0.83 | 100.00 | |||
| Isoform 3 | 7o80.6.A | monomer | 0.58 | 15.46 | |||
| Isoform 3 | 7o80.6.A | monomer | 0.57 | 13.00 | |||